Management of severe sepsis: role of "bundles".
Indian J Chest Dis Allied Sci
;
2009 Jan-Mar; 51(1): 27-36
Article
in English
| IMSEAR
| ID: sea-30207
ABSTRACT
Sepsis is the leading cause of hospital admissions, morbidity and mortality. Treating sepsis is expensive resulting in consumption of major health care resources. With development of newer and potent antimicrobial agents, moratlity due to sepsis has reduced markedly, but remains unacceptably high. Recently, various strategies like fluid therapy, low dose corticosteroids, tight glycaemic control, recombinant human activated protein C [(rhAPC), drotrecogin alfa] and lung protective ventilation have shown favourable results. Further, it is thought that combination of these strategies in the form of "bundles" can further improve the outcome. Concerted utilisation of the "sepsis bundles" is likely to improve outcome of this serious disorder.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Respiratory Insufficiency
/
Shock, Septic
/
Steroids
/
Recombinant Proteins
/
Humans
/
Protein C
/
Sepsis
/
Anti-Infective Agents
Language:
English
Journal:
Indian J Chest Dis Allied Sci
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS